• Japanese
  • Korean
  • Chinese
Cover Image

Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2012" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial (Pyogenic) Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Bacterial (Pyogenic) Meningitis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Bacterial (Pyogenic) Meningitis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bacterial (Pyogenic) Meningitis
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Novartis Vaccines and Diagnostics, Inc.
      • Clinical Trial Overview of Novartis Vaccines and Diagnostics, Inc.
      • Dainippon Sumitomo Pharma Co., Ltd.
      • Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Sanofi-aventis
      • Clinical Trial Overview of Sanofi-aventis
      • Rgc Funding Limited
      • Clinical Trial Overview of Rgc Funding Limited
      • Bio-Manguinhos
      • Clinical Trial Overview of Bio-Manguinhos
      • Jacobus Pharmaceutical Company
      • Clinical Trial Overview of Jacobus Pharmaceutical Company
      • Serum Institute of India Limited
      • Clinical Trial Overview of Serum Institute of India Limited
      • JN-International Medical Corporation
      • Clinical Trial Overview of JN-International Medical Corporation
      • Venus Remedies Limited
      • Clinical Trial Overview of Venus Remedies Limited
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
    • Clinical Trial Overview of Top Universities / Institutes / Hospitals
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Nederlands Vaccin Instituut
      • Clinical Trial Overview of Nederlands Vaccin Instituut
      • Sado General Hospital
      • Clinical Trial Overview of Sado General Hospital
      • Luanda Hospital
      • Clinical Trial Overview of Luanda Hospital
      • Chhatrapati Shahuji Maharaj Medical University
      • Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University
      • Universitas Padjadjaran
      • Clinical Trial Overview of Universitas Padjadjaran
      • Jiangsu Provincial Center for Disease Control and Prevention
      • Clinical Trial Overview of Jiangsu Provincial Center for Disease Control and Prevention
      • University of Malawi
      • Clinical Trial Overview of University of Malawi
      • Guangxi Medical University
      • Clinical Trial Overview of Guangxi Medical University
      • Liverpool School of Tropical Medicine
      • Clinical Trial Overview of Liverpool School of Tropical Medicine
      • Hospital Universitari de Bellvitge
      • Clinical Trial Overview of Hospital Universitari de Bellvitge
      • University Hospitals
      • Clinical Trial Overview of University Hospitals
      • University of Helsinki
      • Clinical Trial Overview of University of Helsinki
      • Xijing Hospital
      • Clinical Trial Overview of Xijing Hospital
      • St George's University of London
      • Clinical Trial Overview of St George's University of London
      • Rouen University Hospital
      • Clinical Trial Overview of Rouen University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, G7 Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, E7 Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Vaccines and Diagnostics, Inc., 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dainippon Sumitomo Pharma Co., Ltd., 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-aventis, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rgc Funding Limited, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Manguinhos, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by JN-International Medical Corporation, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Venus Remedies Limited, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nederlands Vaccin Instituut, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sado General Hospital, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Luanda Hospital, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chhatrapati Shahuji Maharaj Medical University, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitas Padjadjaran, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jiangsu Provincial Center for Disease Control and Prevention, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Malawi, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangxi Medical University, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Liverpool School of Tropical Medicine, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitari de Bellvitge, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Helsinki, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by St George's University of London, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2012*

List of Figures

  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing